Company: XAIR
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001641172-25-023243
Chunk: 116

Company: Beyond Air, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part II, Item 8
Chunk 116
---
 of contracting with third parties to provide marketing and distribution services for us or for building such capacities
    internally;
  
    ●
    the
    costs of acquiring or undertaking the development and commercialization efforts for additional, future therapeutic applications of
    our product candidates;
  
    ●
    the
    magnitude of our general and administrative expenses; and
  
    ●
    any
    cost that we may incur under current and future in-and-out-licensing arrangements relating to our product candidates.

ITEM
3. Quantitative and Qualitative Disclosures About Market Risk

We
are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial
position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of foreign currency
exchange rates.

ITEM
4. Controls and Procedures

Evaluation
of Disclosure Controls and Procedures

We
carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer
(our principal executive officer) and Chief Financial Officer (our principal financial officer), of the effectiveness of the design and
operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Disclosure controls
and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an
issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management,
including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow
timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and
operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating
the cost-benefit relationship of possible controls and procedures. Based upon our evaluation, our Chief Executive Officer and Chief Financial
Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2025.

Changes
in Internal Control Over Financial Reporting

During
the three months ended June 30, 2025, there were no changes made to our internal control over financial reporting that materially affected,
or that are reasonably likely to materially affect our internal control over financial reporting.

33

PART
II OTHER INFORMATION

ITEM
1. Legal Proceedings

None.

ITEM
1A. Risk Factors

There
have